Nab-sirolimus (combination of sirolimus and everolimus), is a nanoparticle albumin-bound MTOR inhibitor which has shown promising preclinical data with increased MTOR suppression and decreased tumor growth [81]. This evidence concerns the gene MTOR and neoplasm.